Maximus, Inc. (NYSE:MMS) insider Mark Andrekovich sold 5,000 shares of the firm’s stock in a transaction on Tuesday, December 5th. The stock was sold at an average price of $68.80, for a total value of $344,000.00. Following the completion of the sale, the insider now directly owns 22,996 shares of the company’s stock, valued at $1,582,124.80. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Mark Andrekovich also recently made the following trade(s):

  • On Wednesday, November 22nd, Mark Andrekovich sold 5,594 shares of Maximus stock. The stock was sold at an average price of $67.23, for a total value of $376,084.62.

Shares of Maximus, Inc. (NYSE:MMS) traded up $0.03 on Wednesday, hitting $68.80. The company’s stock had a trading volume of 359,800 shares, compared to its average volume of 358,624. The firm has a market cap of $4,530.00, a P/E ratio of 22.11, a PEG ratio of 2.58 and a beta of 1.34. Maximus, Inc. has a twelve month low of $51.74 and a twelve month high of $70.43.

The firm also recently declared a quarterly dividend, which was paid on Thursday, November 30th. Stockholders of record on Wednesday, November 15th were issued a dividend of $0.045 per share. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.26%. The ex-dividend date of this dividend was Tuesday, November 14th. Maximus’s dividend payout ratio is presently 5.68%.

A number of analysts have issued reports on MMS shares. Zacks Investment Research raised Maximus from a “hold” rating to a “buy” rating and set a $73.00 target price for the company in a research note on Wednesday, October 4th. Canaccord Genuity cut their target price on Maximus from $62.00 to $61.00 and set a “hold” rating for the company in a research note on Friday, November 10th. Finally, Robert W. Baird reaffirmed a “hold” rating and issued a $64.00 target price on shares of Maximus in a research note on Friday, September 1st. Two equities research analysts have rated the stock with a sell rating and six have issued a hold rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $64.33.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in MMS. Acrospire Investment Management LLC grew its holdings in shares of Maximus by 17.6% during the 2nd quarter. Acrospire Investment Management LLC now owns 2,000 shares of the health services provider’s stock worth $125,000 after purchasing an additional 300 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Maximus by 10.2% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,367 shares of the health services provider’s stock worth $148,000 after purchasing an additional 220 shares during the period. First Bank & Trust grew its holdings in shares of Maximus by 4.2% during the 2nd quarter. First Bank & Trust now owns 2,507 shares of the health services provider’s stock worth $157,000 after purchasing an additional 101 shares during the period. Intl Fcstone Inc. purchased a new position in shares of Maximus during the 2nd quarter worth $201,000. Finally, GW Henssler & Associates Ltd. purchased a new position in shares of Maximus during the 2nd quarter worth $205,000. Institutional investors and hedge funds own 94.82% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/12/06/insider-selling-maximus-inc-mms-insider-sells-5000-shares-of-stock.html.

Maximus Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.